The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 28, 2009
Filed:
Mar. 24, 2004
Nobuhiko Fushimi, Hotaka-machi, JP;
Shigeru Yonekubo, Hotaka-machi, JP;
Hideyuki Muranaka, Hotaka-machi, JP;
Hiroaki Shiohara, Hotaka-machi, JP;
Hirotaka Teranishi, Hotaka-machi, JP;
Kazuo Shimizu, Hotaka-machi, JP;
Fumiaki Ito, Hotaka-machi, JP;
Masayuki Isaji, Hotaka-machi, JP;
Nobuhiko Fushimi, Hotaka-machi, JP;
Shigeru Yonekubo, Hotaka-machi, JP;
Hideyuki Muranaka, Hotaka-machi, JP;
Hiroaki Shiohara, Hotaka-machi, JP;
Hirotaka Teranishi, Hotaka-machi, JP;
Kazuo Shimizu, Hotaka-machi, JP;
Fumiaki Ito, Hotaka-machi, JP;
Masayuki Isaji, Hotaka-machi, JP;
Kissei Pharmaceutical Co., Ltd., Nagano, JP;
Abstract
The present invention provides fused heterocyclic derivatives represented by the general formula: wherein Rrepresents H, halogen, OH, etc.; Rrepresents H, halogen or an alkyl group; Rand Rrepresent H, OH, halogen, etc.; Q represents alkylene, etc.; ring A represents aryl or heteroaryl; and G represents or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity, pharmaceutical compositions comprising the same, and pharmaceutical uses thereof.